Skip to main content Deutsch

News

Novel Model Enables Research of Individual Immune Responses for Colorectal Cancer

(Vienna, 15 November 2024) Predicting the optimal therapy for individual cancer patients is one of the most important goals of modern medicine. A…

Common Food Supplement could unlock cancer secret - Study shows selenium limitation could provide clue to new treatment

(Glasgow/Vienna, 22-October 2024) A study on an essential mineral abundant in brazil nuts could unlock the key to preventing the spread of triple…

Symposium: Leopold Freund - Pioneer of radiotherapy

As a pioneer of radiotherapy, Leopold Freund helped found and shape the "Vienna School of Radiotherapy". He was one of the first three physicians to…

CD-Labor für patient:innenzentrierte Brustbildgebung eröffnet - Forschung soll Brustkrebsdiagnostik sanfter, sicherer und smarter machen

Breast cancer, by far the most common cancer in women, is all the more treatable the earlier it is detected. At MedUni Vienna's newly opened Christian…

"Infinity enzyme" telomerase as a possible starting point for colon cancer therapies

A recent study led by Klaus Holzmann, Medical University of Vienna, Comprehensive Cancer Center Vienna, Center for Cancer Research, has shown that the…

BENEFIZMUSICAL, enjoying culture - helping children

Brain tumours are the most common tumours in children and adolescents. Our modern research facility is working to improve diagnosis and treatment…

Colorectal cancer: New approach for better efficacy of immunotherapies

The most common form of colorectal cancer, microsatellite-stable colorectal cancer (MSS CRC), can currently only be treated to a limited extent with…

Carcinogenic or not? Toxicology course starts in November with new curriculum In-demand risk managers test chemicals for safety.

Chemicals in fashion items, plasticizers in children's toys, dyes in wall paint or ingredients in medicines - all chemicals in use must undergo…

New approach to improve targeted skin cancer therapies

Study provides clues to the molecular background of side effects

Dynamic changes in the immune system of the lung during breast cancer metastasis

Study could provide basis for development of immunotherapies against metastases